Routine Admission to Intensive Care Unit After Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy: Not Always a Requirement

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Annals of Surgical Oncology

• Publication date

  2016-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1245/s10434-015-4963-8PMID 26572753PMCID PMC4816664
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Outcome of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy on Patients with Diaphragmatic Involvement

  2015cited by this paper
• Does intermediate care improve patient outcomes or reduce costs?

  2015cited by this paper
• A Randomized Trial of Goal Directed vs Standard Fluid Therapy in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy

  2015cited by this paper
• Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients.

  2014cited by this paper
• Intensive Care Unit Admission after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Is It Necessary?

  2014cited by this paper
• Morbidity, mortality, and oncological outcomes of 401 consecutive cytoreductive procedures with hyperthermic intraperitoneal chemotherapy (HIPEC)

  2014cited by this paper
• Postoperative Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Affect Long-term Outcome of Patients With Peritoneal Metastases From Colorectal Cancer: a Two-Center Study of 101 Patients

  2014cited by this paper
• Peritoneal Surface Disease (PSD) from Appendiceal Cancer Treated with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Overview of 481 Cases

  2014cited by this paper
• Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older Than 70 Years; Survival Benefit at Considerable Morbidity and Mortality

  2013cited by this paper
• Learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies: Analysis of two centres

  2013cited by this paper
• Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients.

  2013cited by this paper
• Anesthetic management in patients undergoing hyperthermic chemotherapy.

  2012cited by this paper
• Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

  2012cited by this paper
• Eliminating waste in US health care.

  2012cited by this paper
• Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy.

  2012cited by this paper
• Perioperative Management of Patients Undergoing Cytoreductive Surgery Combined with Heated Intraperitoneal Chemotherapy for Peritoneal Surface Malignancy: A Multi-Institutional Experience

  2012cited by this paper
• Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy

  2010cited by this paper
• The older adult driver with cognitive impairment: "It's a very frustrating life".

  2010cited by this paper
• Critical care medicine in the United States 2000–2005: An analysis of bed numbers, occupancy rates, payer mix, and costs*

  2010cited by this paper
• Variation in critical care beds per capita in the United States: implications for pandemic and disaster planning.

  2010cited by this paper
• Variation in hospital mortality associated with inpatient surgery.

  2009cited by this paper
• Should the Treatment of Peritoneal Carcinomatosis by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Still be Regarded as a Highly Morbid Procedure?: A Systematic Review of Morbidity and Mortality

  2009cited by this paper
• Can the costs of critical care be controlled?

  2009cited by this paper
• Complications, Failure to Rescue, and Mortality With Major Inpatient Surgery in Medicare Patients

  2009cited by this paper
• Variation in critical care services across North America and Western Europe*

  2008cited by this paper
• Goal-directed intraoperative therapy reduces morbidity and length of hospital stay in high-risk surgical patients.

  2007cited by this paper
• Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey

  2004cited by this paper
• Trends in U.S. health care spending, 2001.

  2003cited by this paper
• Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.

  2003cited by this paper
• Federal and nationwide intensive care units and healthcare costs: 1986–1992

  1994cited by this paper

• CHALLENGES OF (POSTOPERATIVE) CANCER PATIENTS IN THE ICU

  2025cites this paper
• Implementation of enhanced recovery protocols in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for metastatic ovarian cancer following neoadjuvant chemotherapy. A feasibility study

  2024cites this paper
• Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer

  2023cites this paper
• Predictors of Financial Toxicity Risk Among Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS–HIPEC)

  2023cites this paper
• Developing a hyperthermic intraperitoneal chemotherapy (HIPEC) gynecologic oncology program: a Canadian experience

  2023cites this paper
• Is routine admission to a critical care setting following hyperthermic intraperitoneal chemotherapy for ovarian cancer necessary?

  2023cites this paper
• Early Postoperative Extubation is Associated with Shorter Hospitalization and Improved Short-Term Survival in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

  2022influential citation
• Optimizing risk factors influence Intensive Care stay after Hyperthermic Intraperitoneal Chemotherapy? An observational cohort study.

  2022cites this paper
• Rethinking Routine Intensive Care After Cytoreductive Surgery With Heated Intraperitoneal Chemotherapy: The Fiscal Argument

  2022influential citation
• Neutrophil to lymphocyte ratio based perioperative prediction of prognosis model on early mortality after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.

  2022cites this paper
• Standardizing HIPEC and perioperative care for patients with ovarian cancer in the Netherlands using a Delphi-based consensus

  2022cites this paper
• The Impact of Multidisciplinary Team Approach on Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis

  2021cites this paper
• Peritoneal Cancers and Hyperthermic Intraperitoneal Chemotherapy.

  2020cites this paper
• Hematological toxicities associated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

  2020cites this paper
• What Drives High Costs of Cytoreductive Surgery and HIPEC: Patient, Provider or Tumor?

  2020cites this paper
• A guide to establishing a hyperthermic intraperitoneal chemotherapy program in gynecologic oncology.

  2020influential citation
• Society of Onco-Anaesthesia and Perioperative Care consensus guidelines for perioperative management of patients for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)

  2019cites this paper
• Routine intensive care unit admission among patients undergoing major pancreatic surgery for cancer: No effect on failure to rescue

  2019cites this paper
• Critical Care Admissions and Discharge Criteria in Cancer Patients

  2019cites this paper
• Routine Intensive Care Unit Admission Following Liver Resection: What Is the Value Proposition?

  2019cites this paper
• Intensive Care Practice in the Cancer Patient Population: Special Considerations and Challenges

  2018cites this paper
• Techniques for Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy

  2018cites this paper
• Anaesthesia for Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

  2018cites this paper
• Anaesthetic management and perioperative outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: A retrospective analysis

  2018cites this paper
• Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal malignancy: preliminary results of a multi-disciplinary teamwork model in Asia

  2018cites this paper
• Critical Care Admissions and Discharge Criteria in Cancer Patients

  2018cites this paper
• Peritoneal metastases of colorectal origin - cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). The financial aspect.

  2017cites this paper
• Critical care management and intensive care unit outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy

  2017cites this paper
• Best practice for perioperative management of patients with cytoreductive surgery and HIPEC.

  2017cites this paper
• Current practice in cytoreductive surgery and HIPEC for metastatic peritoneal disease: Spanish multicentric survey.

  2017cites this paper
• Regional Therapies for Advanced Cancer: Update for 2016

  2016cites this paper
• Morbi-mortalité précoce après chimiothérapie hyperthermique intra-péritonéale au Centre Hospitalo-Universitaire de Rouen : étude prospective

  2016influential citation